School of Medicine

Wayne State University School of Medicine









GRANT PROGRAMS

 

Starting with the March 1, 2007 Children’s Research Center of Michigan (CRCM) grant submission deadline, a number of changes will take effect that impact current CRCM grant programs. This introductory section only highlights these changes. You are encouraged to read the corresponding sections below for more details. There are two major changes in the programs. The first is that there are now four (4) possible funding opportunities for investigators engaged in RESEARCH RELEVANT TO THE MISSIONS OF THE CRCM AND CHILDREN’S HOSPITAL OF MICHIGAN (CHM).

The 4 programs are:

  1. A New Investigator Grant Program (NIGP) - up to $50,000/year for up to two years - is for faculty members who have not been funded by extramural sources such as the NIH, foundations or companies. The requirements and rules pertaining to this program are described below.
  2. An Experienced Investigator Grant Program (EIGP) - up to $25,000 for one year - is for faculty members who currently have or have had extramural support from the NIH, foundations or companies and now wish to develop new areas of research or new approaches towards their current interests. The requirements and rules for this program are also described below.
  3. The Small Grant Program (SGP) remains unchanged. The requirements and rules pertaining to this program are detailed below.
  4. The Request for Proposals Grant Program (RFPGP) remains unchanged. From time-to-time, the CRCM may publish Requests for Proposals.


The second change in the CRCM Grant Programs is that all grant proposals will be evaluated only by reviewers, preferably extramural, who are experts in the topic area. Grant proposals will no longer be reviewed by the CRCM Grant Program Committee, which has been disbanded. The reviewers will be asked to evaluate grant applications in terms of their innovativeness, significance, approach, feasibility, and potential to be competitive for subsequent funding by extramural agencies. As in the past, all investigators are encouraged to speak with the CRCM Director before applying for one or more of these funding programs as these discussions can often clarify and facilitate the process.
All applicants are required to use the forms provided through the link below. Applicants must follow all of the directions to complete these forms UNLESS otherwise instructed in the text below.

ELIGIBILITY REQUIREMENTS

  • Applications for research grants may be submitted by faculty or equivalent staff (defined as individuals who can apply for extramural support for which Wayne State University (WSU) or the Detroit Medical Center (DMC) acts as the fiduciary) from any component or unit of CHM, WSU or the DMC. However, for support by the CRCM, CLEAR AND COMPELLING evidence that the proposed investigations are relevant to the missions of the CRCM and CHM must be presented.
  • Applicants from Departments other than Pediatrics or other CHM-departments/divisions are STRONGLY encouraged to recruit a co-investigator who is a faculty member in the Department of Pediatrics or whose appointment is directly related to CHM. The co-investigators must be real and active participants in the proposed research. Applications that do not satisfy this recommendation may be at a disadvantage.
  • Fellows, residents and students cannot apply for support using this mechanism. For these individuals, other funding sources are available. For further information about funding for fellows, residents and students, please contact the CRCM office.
  • Grant support may not be used to supplement research projects already being supported by the Public Health Service, NIH, private or public foundations, or from other sources
  • A Principal Investigator may only submit one proposal for any application deadline and may have only one active grant award in any funding cycle. In addition, if an award is made and activated, the awardee may not submit a new application that could be funded during the year following termination of the last funded application (e.g., a grant terminates on June 30th - the next earliest funding date would be July 1st of the following year. Thus, the earliest submission deadline would be March 1st preceding that July 1 start date).
  • Grant support may not be requested for thesis or dissertation research.
  • If the application is not funded, it may be resubmitted two additional times (2 revisions). For revisions, the investigator must include an additional page of introduction that explains how the grant application has been changed. Also, the investigator must highlight these changes in the text by using UNDERLINED BOLDFACE ITALICS.
  • Racial/ethnic minority individuals, women, and persons with disabilities are encouraged to apply as Principal Investigators.

MECHANISM OF SUPPORT

There are four (4) funding mechanisms. These are: the New Investigator Grant Program (NIGP) - up to $50,000/year for up to two years - is for faculty members who have not been funded by extramural sources such as the NIH, foundations or companies; an Experienced Investigator Grant Program (EIGP) - up to $25,000 for one year - is for faculty members who currently have or have had extramural support from the NIH, foundations or companies and now wish to develop new areas of research or new approaches towards their current interests; the Small Grant Program (SGP); and, a Request for Proposals Grant Program (RFPGP).

  • The SGP is for preliminary/pilot research efforts. An investigator may request funding up to $10,000 for work to be completed within one year from initiation of the grant award. In order to be considered for this mechanism of support, all other rules contained in the description of Grant Programs apply unless specifically abridged, changed, or excluded. An applicant for the SGP must follow all of the rules and procedures, and use the same forms (the link to forms is shown above on this Webpage) required for the other grant programs. Submission and evaluation of applications to the SGP are on a rolling basis and, therefore, there are no set deadlines. Evaluations of these applications will be made by the CRCM Advisory Committee and outside reviewers who are experts in the area of inquiry.
  • The NIGP, which also uses the forms linked to this Webpage, may be requested for up to two years at up to $50,000 per year for direct costs. No support for indirect costs will be provided and an award is not renewable. The award of funding for the second year of support will ONLY be made upon the submission to the CRCM of a timely and complete progress report. Investigators must submit the progress report at least six weeks before the anniversary date for their grant. Failure to submit a progress report will result in the suspension of continuing support until such time that the progress report is submitted, reviewed and judged meritorious. When support for the second year of activity is recommended, it will be allocated in two phases. One half of the support for the second year of research efforts will be made available immediately but the second half will be awarded only if the CRCM is provided with a copy of a grant application that the investigator plans to submit to an outside funding organization, which can be federal, state, local or private. Absent the provision of a grant application, the CRCM may decide not to award the second half of funding for the 02 year research year.
  • The EIGP, which also uses the forms linked to this Webpage, provides up to $25,000 for one year of research efforts. This program is intended for faculty members who currently have or have had extramural support from the NIH, foundations or companies and now wish to develop new areas of research or new approaches towards their current interests. “New areas of research” or “new approaches” toward current investigatory interests are stringently defined. Because of individual circumstances, potential applicants for this program MUST discuss their research intentions with the CRCM Director BEFORE they apply for funding. Under no circumstances will support be provided for indirect costs nor is an award renewable. Investigators must submit the progress report at least six weeks before the anniversary date for their grant.
  • Support can be used for faculty salary, research associates and technicians. However, for faculty salary support, only up to 5% of the applicable NIH maximum for this category can be requested AND the applicant's department must, in writing, agree to pay 2.5% of this amount with the CRCM funding the other 2.5%. Support cannot be used for travel, secretarial services or other services ordinarily provided by CHM, WSU or the DMC. Grant support can be used for small pieces of equipment (not to exceed a total of $5,000), and supplies.
  • Under special circumstances, a no-cost extension of up to 1 year, not to exceed the equivalent of 6 month's budget, may be granted prior to expiration of the project period. All requests for an extension MUST be submitted to the CRCM Director at least 6 months before the end of the funding period.
  • Rebudgeting between line items in excess of $1000 requires the approval of the CRCM.

RESEARCH OBJECTIVES

  • These grant programs provide limited and relatively rapid financial support for research within the program interests of the CRCM and CHM.
  • Funding decisions will be based on scientific merit as determined by peer review, with priority given to applications in any of the following three categories:
    1. Newer, less experienced investigators.
    2. More experienced investigators, for exploratory studies that represent significant change in research direction.
    3. More experienced investigators, for testing new methods or techniques.
  • Applications MUST include an introductory paragraph in the research plan section of the application identifying which priority category (1 through 3 above) is relevant and providing explicit justification for its applicability. Failure to provide this introductory paragraph will result in the application being returned to the investigator without comment or consideration.
  • If the application does not fall into any of the priority categories, this should be stated.
  • While applications may involve a wide variety of biomedical, behavioral, or clinical disciplines, relevance to the mission of the CRCM and CHM must be clear.
  • Applications for studies outside these areas will be returned without review.
  • Potential applicants with questions concerning acceptability of their proposed work may contact Dr. William D. Lyman, Director, Children’s Research Center of Michigan, 3737 Beaubien, Detroit, MI 48201. Tel. (313) 745-2400, Fax (313) 745-0282, E-mail wlyman@med.wayne.edu.

 

INCLUSION OF CHILDREN, WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS

  • It is the policy of the CRCM that children, women and members of minority groups and their subpopulations must be included in all CRCM-supported biomedical and behavioral research projects involving human subjects, unless a clear and compelling rationale and justification are provided that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research.
  • All investigators proposing research involving human subjects should read the "NIH Guidelines For Inclusion of Women and Minorities as Subjects in Clinical Research," which have been published in the Federal Register of March 28, 1994 (FR 59 14508-14513) and reprinted in the NIH Guide for Grants and Contracts, Volume 23, Number 11, March 18, 1994.

APPLICATION PROCEDURES

  • In order to reduce the use of paper, all applications are to be submitted as one (1) paper copy with original signatures and electronically as email attachments or on a CD using the last revision of form PHS 398 (the link is provided above). APPLICATIONS FOR THE NIGP AND EIGP WILL BE ACCEPTED UNTIL 4:00 PM ON THE DAY OF THE STANDARD DEADLINE - EITHER MARCH 1ST OR SEPTEMBER 1ST - OF EACH CALENDAR YEAR. Applications must arrive and be logged into the CRCM application database before 4:00PM. Applications that arrive later than this time will be considered for a subsequent grant deadline - at the earliest, 6 months hence. If either March 1 or September 1 is on a Saturday, Sunday or holiday, applications must be received by the CRCM on the last business day before these days. For the SGP and RFPGP, applications will be accepted on a rolling basis (i.e., no deadline).
  • The application must be completed according to the instructions accompanying the PHS 398, with the following exceptions:
  • The narrative portion of the grant application that describes the research plan (items a-d) may not exceed 10 pages of text. Applications exceeding this length will be returned without review. Appendices may not be used to exceed the page limitation.
  • An introductory paragraph to the research plan MUST identify which of the three priority categories listed under RESEARCH OBJECTIVES applies and provide an explanation of how that priority category applies.
  • If the application does not fall into any of the priority areas, this should be stated.
  • All applications will receive critiques and undergo a process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, will be discussed and assigned a priority score.
  • A summary of the grant proposal in lay language MUST accompany the application. The style and content of this summary should be understandable to an individual with a high school education.
  • Also remember, that any publication or abstract based on work wholly or partially funded by the CRCM must acknowledge CRCM's participation (support, etc).
  • Each applicant MUST submit the names, complete current and accurate contact information (addresses, telephone numbers, email addresses) of at least 6 potential grant reviewers who are experts in the field of proposed investigation. These individuals should not be DMC/WSU faculty or staff. Failure to comply with this request will result in the return of the application to the investigator without review or comment.

REVIEW CRITERIA

When reviewing applications for scientific merit, the review committee will consider the following criteria:

  • Innovativeness/significance of the research idea; creativity of the approach
    • Qualifications of the PI and other relevant staff
  • For pilot studies, the potential of the proposed study to be a building block in the development of future research
  • Appropriateness of the proposed approach; i.e. the research design, methods, and analyses
  • Availability and quality of the proposed resources. Appropriateness of the budget for the tasks proposed
  • Adequacy of plans to include both genders and minorities and their subgroups as appropriate for the scientific goals of the research
  • Plans for the recruitment and retention of subjects will also be evaluated
  • The experts who review the application will also examine the provisions for the protection of human and animal subjects, the safety of the research environment, and conformance with the NIH Guidelines for the Inclusion of Women and Minorities as Subjects in Clinical Research
  • In applying the above criteria, reviewers take into consideration the stage of scientific career development of the principal investigator
  • After their review for scientific merit and the assignment of a priority score, reviewers will evaluate the justification provided for the priority category listed for this program. An administrative note in the summary statement documenting the review will reflect their evaluation.

AWARD CRITERIA

  • Funding is dependent on the availability to the CRCM of adequate financial resources.
  • Grant applications must clearly demonstrate that the proposed investigators are directly relevant to the mission of the Children's Research Center of Michigan and Children's Hospital of Michigan.
  • In addition, CRCM staff will consider the reviewers’ evaluation of the justification for the grant priority category.

INQUIRIES

Inquiries are encouraged. The opportunity to clarify any issues or questions from potential applicants is welcome. Direct inquiries regarding programmatic issues to Dr. Lyman at (313) 745-2400 or wlyman@med.wayne.edu.

Funded Projects

 



© 2002 Copyright Wayne State University Board of Governors